232 related articles for article (PubMed ID: 6289731)
1. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Mintz L; Drew WL
Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Woolfrey BF; Fox JM; Quall CO
J Antimicrob Chemother; 1981 Sep; 8(3):205-11. PubMed ID: 6270052
[No Abstract] [Full Text] [Related]
3. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Livermore DM; Williams RJ; Williams JD
J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
[No Abstract] [Full Text] [Related]
4. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
5. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
Dabernat HJ; Delmas C
Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
[TBL] [Abstract][Full Text] [Related]
6. A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.
Pavillard ER; Miles H
Clin Ther; 1980; 3(Spec Issue):134-8. PubMed ID: 6446387
[TBL] [Abstract][Full Text] [Related]
7. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Chau PY; Ling J; Ng WS
J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
[TBL] [Abstract][Full Text] [Related]
8. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
9. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
10. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
[No Abstract] [Full Text] [Related]
11. Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.
Yu PK; Edson RS; Washington JA; Hermans PE
Antimicrob Agents Chemother; 1983 Jan; 23(1):179-81. PubMed ID: 6219619
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.
Anderson EL; Gramling PK; Vestal PR; Farrar WE
Antimicrob Agents Chemother; 1975 Sep; 8(3):300-4. PubMed ID: 810083
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Magnussen CR; Sammartino MT; Ernest KD
Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Miller MA; LeFrock JL; Vercler MJ
Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
[TBL] [Abstract][Full Text] [Related]
17. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
18. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Murray PR
Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
[TBL] [Abstract][Full Text] [Related]
19. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
Cluzel M; Chanal M; Sirot J; Cluzel R
Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
